Literature DB >> 14871223

FAMMM syndrome: pathogenesis and management.

Rafał Czajkowski1, Waldemar Placek, Gerard Drewa, Aldona Czajkowska, Grazyna Uchańska.   

Abstract

Familial atypical multiple mole melanoma (FAMMM) syndrome is an autosomal dominant disorder with variable incomplete penetrance of the clinical phenotypes. Pathogenesis of this syndrome has not been fully investigated. Across multiple studies, germline mutations in the INK4a antioncogene encoding p16 protein were found on average in approximately 40% of the FAMMM syndrome. Patients with the FAMMM syndrome are genetically loaded with an increased risk of developing melanoma and other malignant neoplasms, for example, a pancreatic cancer. Melanoma can develop from numerous atypical moles as well as de novo. A proper diagnosis of the syndrome and early application of prophylactics decreases the risk of neoplastic transformation of melanocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871223     DOI: 10.1111/j.1524-4725.2004.30088.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

Review 1.  Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Authors:  Laura Fitzpatrick; Jennifer L Hay
Journal:  Melanoma Manag       Date:  2014-12-04

Review 2.  Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.

Authors:  Efthymia Soura; Philip J Eliades; Kristen Shannon; Alexander J Stratigos; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2016-03       Impact factor: 11.527

3.  Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what's worse?

Authors:  Georgi Tchernev; Julian Ananiev; José-Carlos Cardoso; Anastasiya Atanasova Chokoeva; Stanislav Philipov; Plamen Kolev Penev; Torello Lotti; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-08-06

4.  Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database.

Authors:  Tianhui Chen; Mahdi Fallah; Elham Kharazmi; Jianguang Ji; Kristina Sundquist; Kari Hemminki
Journal:  J Invest Dermatol       Date:  2013-11-05       Impact factor: 8.551

Review 5.  An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.

Authors:  Maria J Baker; Alisa M Goldstein; Patricia L Gordon; Kimberly S Harbaugh; Heath B Mackley; Michael J Glantz; Joseph J Drabick
Journal:  J Med Genet       Date:  2016-01-21       Impact factor: 6.318

6.  Familial atypical multiple mole melanoma syndrome in an adult Indian male-case report and literature review.

Authors:  Radhika Cg Raj; Rajesh Patil
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 7.  Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants.

Authors:  Kristen Pauley; Ambreen Khan; Wendy Kohlmann; Joanne Jeter
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

8.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.